Colin Broom
2016
In 2016, Colin Broom earned a total compensation of $1.2M as Chief Executive Officer at Nabriva Therapeutics AG, a 65% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $183,501 |
|---|---|
| Option Awards | $506,756 |
| Salary | $431,766 |
| Other | $43,371 |
| Total | $1,165,394 |
Broom received $506.8K in option awards, accounting for 43% of the total pay in 2016.
Broom also received $183.5K in non-equity incentive plan, $431.8K in salary and $43.4K in other compensation.
Rankings
In 2016, Colin Broom's compensation ranked 7,495th out of 14,075 executives tracked by ExecPay. In other words, Broom earned more than 46.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,495 out of 14,075 | 47th |
Division Manufacturing | 2,837 out of 5,486 | 48th |
Major group Chemicals And Allied Products | 938 out of 1,900 | 51st |
Industry group Drugs | 725 out of 1,543 | 53rd |
Industry Pharmaceutical Preparations | 578 out of 1,173 | 51st |
Source: SEC filing on August 18, 2017.
Broom's colleagues
We found two more compensation records of executives who worked with Colin Broom at Nabriva Therapeutics AG in 2016.